DANIEL GUTIERREZ: Open Payments
NPI 1295126464 · SEBASTIAN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,613 in 74 payments from 18 companies in 2025. Trend: 2023 $1,687 · 2024 $1,665 · 2025 $1,613
Food & beverage: $1,436Education: $177
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 13 | $389 |
| E.R. Squibb & Sons, L.L.C. | 7 | $177 |
| GENZYME CORPORATION | 7 | $150 |
| ABBVIE INC. | 10 | $141 |
| Novartis Pharmaceuticals Corporation | 4 | $104 |
| Galderma Laboratories, L.P. | 6 | $103 |
| PFIZER INC. | 4 | $90 |
| Amgen Inc. | 4 | $90 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $60 |
| Janssen Biotech, Inc. | 3 | $55 |
Products named: DUPIXENT, Sotyktu, OTEZLA, NEMLUVIO, RINVOQ, SPEVIGO, COSENTYX, CIBINQO.
Industry payments across FL — which companies pay providers there.
